4//SEC Filing
THERASENSE INC 4
Accession 0001267399-04-000028
CIK 0001073695operating
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 2:31 PM ET
Size
25.2 KB
Accession
0001267399-04-000028
Insider Transaction Report
Form 4
THERASENSE INCTHER
LAM NELSON
VP of QA and RA
Transactions
- Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$21.50/sh−4,950$106,425→ 0 totalExercise: $5.50From: 1988-08-08Exp: 2011-01-26→ Common Stock (4,950 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$19.91/sh−5,242$104,368→ 0 totalExercise: $7.09From: 1988-08-08Exp: 2013-02-25→ Common Stock (5,242 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$18.00/sh−5,209$93,762→ 0 totalExercise: $9.00From: 1988-08-08Exp: 2011-08-03→ Common Stock (5,209 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$6.51/sh−9,585$62,398→ 0 totalExercise: $20.49From: 1988-08-08Exp: 2012-01-29→ Common Stock (9,585 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$22.00/sh−6,250$137,500→ 0 totalExercise: $5.00From: 1988-08-08Exp: 2010-11-03→ Common Stock (6,250 underlying) - Disposition to Issuer
Common Stock
2004-04-05$27.00/sh−1,936$52,272→ 0 total - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$13.27/sh−110,000$1,459,700→ 0 totalExercise: $13.73From: 1988-08-08Exp: 2013-08-26→ Common Stock (110,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$24.00/sh−582$13,968→ 0 totalExercise: $3.00From: 1988-08-08Exp: 2010-03-17→ Common Stock (582 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$6.80/sh−26,287$178,752→ 0 totalExercise: $20.20From: 1988-08-08Exp: 2014-01-05→ Common Stock (26,287 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$23.00/sh−1,375$31,625→ 0 totalExercise: $4.00From: 1988-08-08Exp: 2010-07-31→ Common Stock (1,375 underlying)
Footnotes (3)
- [F1]Includes 1,936 shares acquired under the TheraSense, Inc. Employee Stock Purchase Plan on April 2, 2004.
- [F2]Disposed of pursuant to a merger agreement between the issuer, Abbott Laboratories and a wholly-owned subsidiary of Abbott Laboratories.
- [F3]This option provided for vesting over a four year period and was cancelled pursuant to the merger agreement between the issuer, Abbott Laboratories and a wholly-owned subsidiary of Abbott Laboratories in exchange for a cash payment per underlying share equal to $27.00 less the exercise price.
Documents
Issuer
THERASENSE INC
CIK 0001073695
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0001073695
Filing Metadata
- Form type
- 4
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 2:31 PM ET
- Size
- 25.2 KB